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Background: With the increasing pace of new Genetically Modified Organisms (GMOs) authorized or in pipeline for
commercialization worldwide, the task of the laboratories in charge to test the compliance of food, feed or seed
samples with their relevant regulations became difficult and costly. Many of them have already adopted the so
called “matrix approach” to rationalize the resources and efforts used to increase their efficiency within a limited
budget. Most of the time, the “matrix approach” is implemented using limited information and some proprietary
(if any) computational tool to efficiently use the available data.
Results: The developed GMOseek software is designed to support decision making in all the phases of routine
GMO laboratory testing, including the interpretation of wet-lab results. The tool makes use of a tabulated matrix
of GM events and their genetic elements, of the laboratory analysis history and the available information about
the sample at hand. The tool uses an optimization approach to suggest the most suited screening assays for the
given sample. The practical GMOseek user interface allows the user to customize the search for a cost-efficient
combination of screening assays to be employed on a given sample. It further guides the user to select appropriate
analyses to determine the presence of individual GM events in the analyzed sample, and it helps taking a final
decision regarding the GMO composition in the sample. GMOseek can also be used to evaluate new, previously
unused GMO screening targets and to estimate the profitability of developing new GMO screening methods.
Conclusion: The presented freely available software tool offers the GMO testing laboratories the possibility to select
combinations of assays (e.g. quantitative real-time PCR tests) needed for their task, by allowing the expert to express
his/her preferences in terms of multiplexing and cost. The utility of GMOseek is exemplified by analyzing selected food,
feed and seed samples from a national reference laboratory for GMO testing and by comparing its performance to
existing tools which use the matrix approach. GMOseek proves superior when tested on real samples in terms of GMO
coverage and cost efficiency of its screening strategies, including its capacity of simple interpretation of the testing
results.
Keywords: Genetically Modified Organism, Matrix approach, Constraint optimization, Cost efficient GMO testingBackground
Since the first commercialization in 1996, genetically
modified organisms (GMOs) have gained significant
shares in agriculture and food chains at a global scale
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A GMO is an organism whose genome was modified
by introducing a foreign genetic construct (a transgene)
consisting of several genetic components (gene of inte-
rest, regulatory sequences for the gene to enable its
function in the host organism, etc.…). Therefore, the
most appropriate methods for GMO detection are based
on testing the presence of the DNA sequence of a given
GMO (called “event”). To date, the preferred technique
to perform these tests is the Polymerase Chain Reaction
(PCR) or its derivative real-time PCR [3-6]. The PCR
assays can target commonly used genetic componentsl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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(screening tests) [4], or they can aim at identifying the
specific signature of one given GM event for identifica-
tion purposes (event-specific tests) [7].
Together with the increasing number of genetically
modified (GM) events commercialized and in pipeline for
commercialization in the recent years, their complexity
and diversity in terms of the crop taxa and genes involved
have grown rapidly. As a consequence, the screening
phase became more complicated with less obvious combi-
nations of screening tests to cover a wide range of GM
events. Regarding the identification phase and given the
high number of GM events to be scrutinized, using only
event-specific assays is not economically sustainable and
is limited to the detection of known events only.
To face the challenge of maintaining the cost of GMO
analysis affordable with an enhancing spectrum of candi-
dates to be detected, the so-called “matrix approach” [8]
has been adopted by numerous laboratories, i.e. the mem-
bers of the European Network of GMO Laboratories
(ENGL). The matrix is a tabulated dataset in which each
row represents a specific GM event and the columns rep-
resent the genetic elements composing the GM event
which can be used as targets for analytical test methods.
The matrix approach combines the use of screening and
event-specific assays [9-12]. The screening phase employs
combinations of screening assays allowing a large coverage
of GM events. By comparing the results of these assays
with tabulated data about the theoretical presence/absence
of the targeted components in individual events (the
matrix), the analyst discards the GM events not detected
(and therefore assumed to be absent) in the tested sample.
Event-specific assays are then used in the subsequent ana-
lytic phase for identifying the GM event(s) present in the
sample. In the case that the identified GM event(s) does
(do) not match with the screening results pattern, further
analysis has to be performed to elucidate the origin of the
unexplained positive signals [5,12-14]. The advantage of
the matrix approach is the reduced number of PCR tests
needed to achieve the identification of the GM event(s)
present in the sample and/or to conclude on the compli-
ance of the tested sample.
Two key elements lead to the correct use of the matrix
approach: availability of information regarding the genetic
components in the individual GM events, and correct use
of this information and results of tests to achieve proper
conclusions regarding the sample compliance with the
GMO regulations.
Since its first introduction within the European FP5
GMOchips project [15], the implementation of the matrix
approach was limited due to the dispersion and lack of
completeness of the information regarding the GMO
genetic components found in several databases, which are
mainly dedicated to GMO risk assessment [16-21]. Severalindividual efforts were made to demonstrate the use of the
matrix approach in GMO analysis [10-12,22,23]. Recently,
a coordinated effort under the framework of the European
ERA-NET GMOseek project led to the compilation of the
most comprehensive set of data dedicated to the im-
plementation of the matrix approach. This set of data has
since been made available [8].
The matrix approach has three main steps: 1) selection
of the screening assays to be used in the first analytical
phase, 2) comparison of the screening results with the
tabulated data to decide on the next, identification phase
(using event-specific assays), 3) the interpretation of
both the screening and identification phase patterns to
correctly conclude on the sample composition in terms
of GM events.
Just a few matrix approach tools are available
[8,11,12,22,23]. These tools are often not amenable for
wide use of the GMO testing community because of
their lack of flexibility and availability. The GMOfinder
tool [23] is not publicly available because of intellectual
property issues, the COSYPS system [11] is limited to
the SYBR®green PCR chemistry, and Excel applications
[12] enable only low combinatory approach to support
decision making in GMO detection. Finally, none of
these tools considers the cost-efficiency of GMO testing,
as they only focus on the identification of the events in
the sample.
In a previous study, we have developed the GMOtrack
tool that finds cost-efficient two-phase (screening–iden-
tification) sample-centered testing strategies [22]. While
that study reports on major cost benefits of using the
sample-centered cost-optimization approach to GMO
testing, the adoption of GMOtrack in routine laborator-
ies was limited by two factors. One major shortcoming
of GMOtrack is limited user unfriendliness and support
only for the first step of the matrix approach - the selec-
tion of screening assays, omitting the selection of ne-
cessary event-specific assays to be performed based on
screening results, and also omitting the support for the
interpretation of the results from both screening and
identification phase to conclude the analysis. The second
issue is that the algorithm used in GMOtrack performs
exhaustive search for finding optimal two-phase testing
strategies.
When GMOtrack was developed in year 2008, an ex-
haustive approach was feasible, as then only 22 GM events
needed to be tested in the EU. However, it is not feasible
to use it with large datasets such as the recent GMOseek
matrix [8], given that more than 50 EU-approved GM
events, and more than 320 GM events and 240 different
genetic elements are listed globally.
The main purpose of this study is to present and
evaluate the GMOseek software tool that upgrades the
GMOtrack tool in several ways. GMOseek uses an
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optimum cost-efficient two-phase sample-centered testing
strategies within large datasets like the matrix described in
[8], utilizing a conventional laboratory computer. GMO-
seek also provides a user-friendly interface with a decision
support system, which guides the user through all the
three steps of the cost-efficient matrix GMO testing ap-
proach: from the selection of screening assays, deciding
on the event-specific assays to be performed and the final
interpretation of the results. The GMOseek tool was
evaluated at the National Reference Laboratory for GMO
testing food and feed (the “TestLab” in the following),
demonstrating its capacity to ease the analyst task and re-
duce the total analysis costs.
The advantages and limitations of the matrix-based
approach have been discussed in recent publications, in-
cluding the issues of the assay sensitivity and specificity
that can be responsible for interpretation errors [8,9,13].
The reader is invited to consult these publications
for further considerations regarding assay performance
when using this approach.
Implementation
GMOseek is a user-friendly software tool with a decision
support system which guides the user through the three
steps of the cost-efficient sample-centered matrix GMO
testing. The software is developed in Java and runs on any
system with a Java Virtual Machine 1.5 or later. It is
packed and deployed as one file which is named GMO.jar.
The program can be freely downloaded from the
web page http://kt.ijs.si/software/GMOtrack/GMOseek.
html or http://www.gmoseek.com/gmoseek placed on a
user’s computer and run by a double click on the file from
a file manager or by java -jar GMOseek.jar from the com-
mand line.
The matrix approach for GMO traceability relies on a
matrix of GM events relevant to the food, feed and seed
legislation and their genetic components. The sample-
centered cost-efficient GMO testing approach used by
GMOseek can additionally incorporate the data about
laboratory analysis history in the form of probability of
GMO presence and information about the sample to be
tested. GMOseek can easily adapt to new situations on
the market by changing the input data matrix, which
includes the data about GMOs, methods (assays) for de-
tecting GMOs and probabilities of GMO presence. The
data format of GMOseek is compatible with the GMO-
track data format. The data can be downloaded from the
project’s website (http://www.gmoseek.com/gmoseek),
where the comprehensive matrix from Block and colla-
borators [8] and another matrix with data about GM
events approved in the EU as well as the events regu-
lated under EC 619/2011 [24] are available to be used
directly with the GMOseek program. These datasets canbe further tailored to a situation at hand by editing in a
spreadsheet program (like OpenOffice Calc or MS Excel)
and save to a tab-separated file.
In the sample-centered approach to analytical GMO
tracking, the testing strategy is tuned to the given sample
in order to minimize the total analysis cost, instead of
using the same testing strategy for all samples. Sample-
centered testing strategies generated by GMOseek have a
screening and an identification phase. To optimize the
total analysis cost, the sample-centered approach finds a
combination of screening assays that best trades off the
screening and the expected event-specific costs. The ex-
pected event-specific cost is estimated from the data in
the matrix, laboratory analysis history and prior know-
ledge about the sample (e.g. is it a food or feed sample).
The GMOseek testing strategies are in-line with the
guidelines for the preparation of GMO screening analysis
using the matrix-based approach as described by Kralj
Novak et al. [22].
The GMOseek system for guiding the analyst through
the three steps of the cost-efficient matrix GMO testing
approach has two main components: the GMOseek algo-
rithm for computing near-optimum two-phase sample-
centered GMO testing strategies and a decision support
system for guiding the analysis and interpreting the re-
sults. The remainder of this section describes the two
main components.
The GMOseek algorithm
The task addressed by the GMOseek algorithm can be for-
mulated as follows: given a matrix of GM events and avail-
able screening assays, prior probabilities of GMO
presence (estimated from historical data) and information
about the species of the sample at hand, find a two-phase
testing strategy with the lowest total expected cost. The
total expected cost of a two-phase testing strategy is the
sum of the screening cost and the expected event-specific
cost, where the expected event-specific cost is computed
from the probabilities of GMO presence. The strategies
either identify the GMO present in the sample by an
event-specific assay or confirm its absence by either a
screening or an event-specific assay for all the GMs in the
dataset.
For more details on probability calculation and cost esti-
mation, see the GMOtrack formal background [22] and
supplementary material available at http://kt.ijs.si/software/
GMOtrack/. As previously described [22], the cost of one
run of PCR assays for the chosen laboratory is a linear
function of the number of assays (numAssays) according
to the equation g(numAssays) = 21.18 · numAssays + 91.82.
It is a simplification of the real situation with a relative ab-
solute error of 3 %. The cost of one run takes into account
both the labor and the material / reagent costs. The
GMOseek cost computation formula is the same, but
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the cost that contribute the most. In this way, the cost
computation can be stopped when the partial cost exceeds
the best cost so far, leading to major computation time
savings.
The GMOseek algorithm uses a smart searching strat-
egy for finding the optimal GMO testing strategy. It
considers the assays that contribute the most to the
coverage of the whole GMO set first in order to quickly
generate a good (in terms of total expected cost) com-
bination of assays. It then generates the other combina-
tions of assays, which are pruned if their cost is higher
than the best cost so far. As the cost computation is very
complex, it is interrupted if the partial cost exceeds the
best cost so far. The algorithm prunes a set of candidate
solutions if the screening phase cost of new candidate
strategies is higher than the total expected cost of the best
solution so far. The algorithm stops when all the candi-
date screening assays are either evaluated or pruned.
The best solution so far, its total expected cost and its
coverage are printed on the interface when generated.
The user can interrupt the search at any time, if he/she
is satisfied with the proposed solution, or continue the
search to the end, waiting for the best solution to be
proved.
The GMOseek decision support system
GMOseek has an interface for entering the information
about the sample at hand and choosing the matrix with
available assays and estimated probabilities of GMO
presence. This information is used by the GMOseek
algorithm to tailor the screening to the given sample.
The combination of screening assays proposed by the
GMOseek algorithm can be used in wet-lab or, alterna-
tively changed and other screening can be performed.
GMOseek has an interface for entering (clicking)
screening wet-lab results. It compares the screening re-
sults with the matrix data on the fly and points out which
event-specific assays need to be performed. Finally, the re-
sult of event-specific testing can be entered and the sys-
tem interprets the results and checks for inconsistencies:
– Positive event-specific tests prove the presence of
respective GM events
– A positive screening assay suggests a positive GM
event, but event-specific results can contradict this
– GMOseek warns for potential stacked genes when
two or more events of the same species are
identified
Finally, GMOseek can also be used to select new
GMO screening targets and estimate the profitability of
developing new GMO screening methods. GMOseek
can be used to see which and if and in which scenario(e.g. change of GMO frequencies, introduction of so far
not authorized GM events) the potential new screening
assays would be used in the optimal testing strategy.
These results should be compared with the cost of tes-
ting with only the existing screening assays, also calcu-
lated by GMOseek. The difference in costs in different
scenarios is a good estimate of the profitability of candi-
dates for new screening assays.
It should be emphasized that all the functionalities of
GMOseek can be used together or separately, as the user
prefers. In many laboratories, users prefer to use a fixed
set of screening assays of their choice. In such a case,
they can still largely benefit from the GMOseek decision
support system for selecting the necessary event-specific
assays that need to be performed based on the screening
results and for interpreting the results of both the
screening and event-specific testing phase.
Results and discussion
This section describes the functionality of the GMOseek
software together with performance and functionality
comparisons with its predecessor, the GMOtrack software.
There is also a discussion of the intended use of the soft-
ware, and the benefits that are envisioned together with
an outline for the planned future development of new
features.
From GMOtrack to GMOseek
GMOseek is the successor of GMOtrack, and its develop-
ment was motivated by the successful applications of
GMOtrack and by the fact that the matrix approach be-
came the most obvious strategy for contemporary GMO
testing. GMOtrack was the first system addressing the
routine laboratory-level GMO tracking as a cost opti-
mization problem. The search procedure of GMOtrack is
exhaustive; this means that the algorithm generates all the
possible combinations of up to m screening assays and se-
lects the one with the lowest expected cost for a sample at
hand. Its applications show major cost benefits of shifting
from “the same strategy for all samples” to “sample-cen-
tered GMO testing strategies”. GMOtrack was developed
at the level of “proof-of-concept”, hence its search proced-
ure for finding the optimal combination of assays for test-
ing a sample at hand was not optimized. Moreover,
GMOtrack has a command-line utility that only suggests
the optimal set of screening assays to be applied in the
screening phase and does not support the interpretation
of wet-lab results. Nevertheless, all the definitions, strat-
egies and other research background defined and de-
veloped within GMOtrack have been incorporated in
GMOseek, which overcomes its predecessor’s deficiencies
and provides new functionalities.
Compared to GMOtrack, the GMOseek algorithm uses
a constraint optimization paradigm to limit the search
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screening assays to get the optimal testing strategy. By
using this approach, large parts of the search space can be
pruned, which leads to a much faster computation. GMO-
seek has a much lower time complexity compared to
GMOtrack, making it feasible to generate testing stra-
tegies comprising combinations of tens of screening assays
selected within a pool of hundreds of potential screening
assays. When used on large datasets, GMOseek can be
stopped before reaching the optimal solution; in such
cases, it does not guarantee to find the optimal testing
strategy. Another major change compared to GMOtrack
is that there is no objective set (constraints) in the search
option in terms of minimum coverage of GM events du-
ring the screening phase, nor the maximum number of
screening events.
We developed the GMOseek system which incorpo-
rates the GMOseek algorithm and a user friendly inter-
face that is designed to support the following steps of
the routine GMO testing laboratory. First, the datasetFigure 1 Search platform of the GMOseek software (part 1). Upper too
load a dataset. Upper toolbar, central command button: Command enabling
right command button: Command opening the help window containing the
choose to select all the species or choose the ones of interest (e.g. the ingred
information about the definition. The information is about chances of a GMO
Lower, middle panel: Once plant species are selected, displays a list of possibl
events. A probability of a negative result of a test is attached to each screenin
tool bar, left command button: Command enabling the search start “find assa
interruption of the search. Lower tool bar, selection field: if marked, this select
platform. Information bar (bottom): Information about the path to the loadedwhich can be tuned to the sample at hand is loaded
(Figure 1). In the data, the probability of appearance of a
GMO incorporates the background knowledge about the
sample (Figure 1). The user chooses the crop species
present in the sample (included also in the dataset
loaded). After activating the search mode, the GMOseek
system then generates the near-optimal testing strategy
for the sample (Figure 2). The user can decide not to
wait until the GMOseek system finds a near-optimal so-
lution by manually interrupting the search and using the
proposed assay combination found so far.
On the inspection panel, the user can visualize the com-
bination of assays obtained during the search phase. This
combination can be completely amended at hand by the
user. When the actual experimental screening is com-
pleted following the combination chosen by the user, the
screening results (positive/negative outcomes) are manu-
ally entered into the GMOseek system (Figure 3). GMO-
seek then suggests which event-specific assays need to be
done to identify the presence of all possible GM events inlbar, left command button: Command enabling to browse, select and
to open a table containing a dataset that was last used. Upper toolbar,
user manual. Left panel: Species present in the data set. The user can
ient of the sample) for the search. Upper, middle panel: contains
appearing in a sample and about a GMO detection of a screening assay.
e GM events and a list of screening assays which can detect these GM
g assay (in a case that the screening assay would be used alone). Lower
y”. Lower tool bar, right command button: Command enabling manual
ion allows transferring the search results (best solution) to the inspection
dataset.
Figure 2 Search platform of the GMOseek software (part 2). Lower, middle panel: During the search process, this panel lists the combinations
of assays found as follows: time (in ms) the solution is found, expected cost of the solution in arbitrary unit. In brackets are indicated the cost if only
event-specific assay would be used, and the savings of the proposed solution in comparison with this “all event-specific strategy”.genetic components
to be targeted. In bracket is indicated the coverage of this screening solution in percentage, and as the ratio of the covered GM events vs. the total
GM events in the dataset.
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tion phase is completed, the event-specific test results are
entered and the GMOseek system interprets them and
provides warning for possible stacked genes and for incon-
sistent results (Figure 3).
The GMOseek tool can be used for many purposes.
The major expected use is for routine laboratory testing,
to choose the best combination of screening assays for a
sample at hand (food, feed, and seeds). Another purpose
of GMOseek is to guide the analyst through the whole
process until the decision making regarding the sample
compliance. For this, the analyst can decide to use the
combinations of screening assays proposed by the sys-
tem or amend it. The inspection platform is independent
from the search platform. Therefore, the user can also
decide to use GMOseek only to interpret the wet-lab
results. Finally, another possible use of GMOseek is to
estimate the profitability of developing new screening
assays, based on the new GM events available on the
(global) market and estimates of their occurrences on
the market. As it was already the case with GMOtrack,
the simple format of the dataset (tabulated matrix) al-
lows the user to tailor his search with GMOseek based
on his/her own needs.The usability of GMOseek tested on different datasets
with increasing sizes (Table 1) is shown in Table 2
As for GMOtrack, the low frequency of a given GM
event does not mean that its genetic elements (target for
potential screening assays) are ignored in the algorithm.
The algorithm is designed in such that the coverage
factor parameter is on an equal footing with the cost
parameter.
Data acquisition and data subsets
The data regarding the known GM events relevant to the
food, feed and seed legislation and their genetic compo-
nents were collected during the European ERA-NET
GMOseek project, and were recently made publicly avail-
able [8].
These data were then transferred into a tabulated matrix
format, required by the GMOseek software (compatible
with the GMOtrack format). Frequencies of presence of
each GM event for the years 2006 to 2012 were gathered
based on the actual observation in our routine GMO
testing laboratory (“TestLab”) and according to the fol-
lowing data and rules. Information about the GMO
authorization status through the years was obtained from
the GMO database hosted by the GMO Compass website
Figure 3 Inspection platform (Decision Support System) of the GMOseek software. Extreme left panel: Species present in the data set. The
user can choose to select all the species or choose the ones of interest (e.g. the ingredient of the sample) for the inspection.Middle left panel:
Screening assays that can be performed for the loaded dataset. The screening assays indicated in black are the ones chosen for the experimental
screening phase. The grey assays are not tested. The user can select the assays to be tested by right clicking on each screening assay. Left
clicking a screening assay indicated the positive outcome of a screening assay (un-ticked screening assays result in negative outcome). Middle
right panel: Event-specific assays that can be performed for the loaded dataset. Depending on the outcomes of the screening phase, GM events
appear green (not present in the sample) or red (possibly present in the sample, to be tested). After the experimental identification phase, the
user indicates the outcome of the event-specific assays, a ticked GMO meaning a positive result of the event-specific assay for this GMO.
Extreme right panel: consistency panel. After clicking on the command button “check consistency”, a message appears indicating the absence
of consistency between the screening phase and identification phases, or eventually the possible inconsistency of the experimental results.
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the European Food Safety Authority (EFSA) register of ques-
tions (http://registerofquestions.efsa.europa.eu/roqFrontend/
questionsListLoader?panel=GMO&questiontype=2). Infor-
mation regarding the presence of unauthorized GMOs











GMO_EU_2005.tab 24 20 55,454
GMO_EU_2008.tab 25 22 68,405
GMO_EU_2010.tab 85 55 102,425
GMO_EU_2012.tab 121 76 295,361
GMO_all_2012.tab 220 247 1,774,850
Number of genetic components: number of components to be considered for the
screening phase assays.
Number of GM events: number of GM events to be covered in the dataset.
Combinations to be computed: number of combinations to be computed to
generate screening sets, according to GMOtrack.the Rapid Alert System for Food and Feed (RASFF) portal
(https://webgate.ec.europa.eu/rasff-window/portal/), and
from the European Network of GMO Laboratories
(ENGL).
If an UGM was never observed in EU, it was assigned a
low probability of one per thousand (0.001). A frequency
of 1% was attributed to UGMs already reported in the EU.
All GM events authorized, tolerated [25], or under the so-
called “low level presence for feed” regulation in the EU
(EC 619/2011) [24], and thereafter termed EU GMO, ob-
served with a frequency below 1% were given a 1% fre-
quency in the dataset. All EU GM events observed with a
frequency above 1% were attributed the actual frequency
observed by the TestLab. All the collected datasets, as-
sembled by years and by sample matrix type (food, feed,
seed, all matrices), are available on the website (http://
www.gmoseek.com/gmoseek).
The GMOseek system is designed to detect all (known)
GMOs. Frequency estimates are used (only) to compute
the probabilities of outcomes of screening assays which
are in turn used to estimate the total expected cost of a
Table 2 Comparison of GMOtrack and GMOseek screening strategies



















GMO_EU_2005.tab 515.42 234.24 4 100 234.24 4 100
GMO_EU_2008.tab 557.78 376.73** 3 86 301.21 6 100
GMO_EU_2010.tab 1256.72 561.72** 3 96 429.06* 9* 100*
GMO_EU_2012.tab 1701.5 861.49** 3 91 592.84* 12* 99*
GMO_all_2012.tab 5280.92 No solution No solution No solution 1907.30* 14* 82*
*Interrupted before optimal result found.
**GMOtrack constrains parameters set to m = 3 (number of screening assays in solution) and coverage = 80% (the minimal coverage (in percentage of the total
GM events in the dataset) of screening assay combinations).
Expected cost (event-specific assays only): cost (in arbitrary unit) of a sample analysis if no screening strategy is followed and only event-specific assays are use.
Lowest analytical cost GMOtrack: cost (in arbitrary unit) of a sample analysis using the best screening assay combination proposed by GMOtrack.
Combination GMOtrack (number assays): number of screening assays to be performed when following the best screening assay combination proposed
by GMOtrack.
Coverage GMOtrack (%): Coverage (in percentage of the total GM events in the dataset) of the best screening assay combination proposed by GMOtrack.
Lowest analytical cost GMOseek: cost (in arbitrary unit) of a sample analysis using the best screening assay combination proposed by GMOseek.
Combination GMOseek (number assays): number of screening assays to be performed when following the best screening assay combination proposed
by GMOseek.
Coverage GMOseek (%): Coverage (in percentage of the total GM events in the dataset) of the best screening assay combination proposed by GMOseek.
Morisset et al. BMC Bioinformatics 2014, 15:258 Page 8 of 13
http://www.biomedcentral.com/1471-2105/15/258combination of screening assays. As it was the case for
GMOtrack [22], the low frequency of a given GM event
does not mean that its genetic elements (target for poten-
tial screening assays) are ignored in the algorithm. The al-
gorithm is designed in a way that the coverage of all GM
events is of utmost importance, while the cost estimate is
used for strategy selection. The goal of this paper is to
propose a very versatile tool and to exemplify its perform-
ance on real-world data. Therefore, users of GMOseek are
recommended to use the data from their own testing his-
tory, or, alternatively, data coming from international
studies.
In the following sections are described subsets of data
employed to perform simulations runs with GMOseek.
These simulations performed selecting all the species
present in the tested datasets were intended to test the
performance, the robustness and the relevance of the
GMOseek package. Note that in the datasets, the soft-
ware and this manuscript, the terms “corn” and “maize”
are identical and refer to the same Zea mays species.
Subsets for GMOtrack vs. GMOseek comparison
For comparing the GMOseek and GMOtrack software,
the datasets GMO_EU_2005.tab and GMO_EU_2008.tab
(Additional files 1 and 2) previously used for the validation
of the GMOtrack software were utilized. Additional data-
sets with increasing data amount for years 2010 and 2012
and for different geographical zone (EU related GM events
only, all GM events known globally) were prepared from
the GMOseek project matrix [8] to be used with both the
GMOseek and GMOtrack software (Additional files 3, 4
and 5). The data set size is indicated in Table 1. GMO-
track simulations were performed with the default settings
(maximum five assays in the screening phase, minimum
80% coverage of all the GM events in the dataset in thescreening phase). As GMOtrack becomes very limited
with growing dataset, this 80% coverage parameter was
chosen to speed-up the generation of results.
Subsets for GMOseek robustness assessment
To assess whether the change in frequency of appea-
rance of GM events would have an influence on the
GMOseek algorithm robustness and the combinations
of assays it proposes, several data subsets for EU GM
events were prepared, then tested and compared with
the subset containing the actual observed frequencies
(“template data set”, Additional file 6).
Equal frequencies
In one experiment, all GM event frequencies were set at
the same level (0.1%, 1%, 2%, 5% and 10%, respectively)
(Additional files 7, 8, 9, 10 and 11). In another
experiment (“Near future”), several scenarios for future
situations were tested (near future 1, 2 and 3) and for
each scenario, evolution of frequency (increase of GMO
occurrence) was also tested.
Near future 1 subsets
These subsets (Additional files 12, 13, 14 and 15) were
created to simulate a probable future situation in EU. In
these subsets, the following modifications were made to
the template EU GMO dataset (Additional file 6):
1) Increase the percentage of all EU authorized/in
pipeline GM events from 1% (or their actual
frequency) to 2%, 5% and 10%, respectively.
2) Decrease the frequency of UGMs found in EU
to 0.1%.
3) Lower the frequency of the tolerated GM events
to 0.1%.
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http://www.biomedcentral.com/1471-2105/15/2584) The actual GTS 40-3-2, most widely planted GMO
in the world (RoundUp Ready soybean – termed
“RRS”, in the following) frequency (46%) stays the
same.
Near future 2 subsets
These subsets are similar as the above described ones
(near future 1). In these subsets (Additional files 16, 17, 18
and 19), the EU GM events for which the first application
for authorization was submitted in 2003 or before (consid-
ered as “old GM events”) see their frequency stagnating.
RRS frequency decreases to 25%, and only the newer
events (first application in EU after 2003) see their fre-
quency increasing from 1% to 2%, 5% and 10%. Data re-
garding the authorization status and submission dates
were obtained from the Community register of genetically
modified food and feed (http://ec.europa.eu/food/dyna/
gm_register/index_en.cfm) and from the GMO compass
database (http://www.gmo-compass.org/eng/gmo/db/).
Near future 3 subsets
These are the same subsets as for near future 2 with the
“old” events (first application for authorization in EU
from 2003 or before) having their frequency decreased
to 0.5%, and RRS frequency decreased to 5%. In these
subsets (Additional files 20, 21, 22 and 23), only the fre-
quencies for the new events (authorization dossier in EU
submitted after 2003) increase from 1% to 2%, 5% and
10%. Two additional files (Additional files 23bis and
23ter) were created based on the last mentioned dataset
(new events at 10%) with one GM event frequency being
set at 80%, and another dataset with four GM event
found with 80% frequency.
5plex subset
In this subset of a template dataset (Additional file 24),
only the genetic components proposed by Waiblinger and
collaborators [12] in their practical approach for detecting
GMOs are targeted, especially because also the pentaplex
(5plex) method was recently published [26]. This 5plex
had a considerable impact on the implementation of the
matrix based approach within the community of GMO
testing laboratories. This subset (Additional file 25) was
created and used to compare the performance of the 5plex
screening strategy with the screening strategies proposed
by the GMOseek algorithm.
GMOseek test results
Robustness to frequency changes
To assess whether the change in frequency of appear-
ance of GMO events would have an influence on the
GMOseek algorithm robustness and the combinations of
assays it proposes, several data subsets for GMOs autho-
rized, tolerated or in pipeline in EU were tested. In oneexperiment (“equal frequencies”), all GM events were set
at the same frequencies ranging from 0.1% to 10%. In
another experiment (“Near future”), several scenarios for
future situations were tested (near future 1, 2 and 3) and
for each scenario, the evolution of frequency (increase of
GMO occurrence) was also tested.Equal frequencies
Details on the results of computation can be found in
Additional file 26. For the currently EU authorized, tol-
erated and in pipeline GMOs, the change of frequencies
has low influence on the GMO coverage and the pro-
posed combinations of screening assays (frequency at 1%
and 2%). The main observed change is the expected cost
saving for the best combination (the lower is the fre-
quency, the larger is the cost saving).
With very low presence of all GM events (0.1%), the
screening combination would be simpler with four scree-
ning elements to be targeted instead of nine genetic
components for frequencies at 1% and 2%). At higher fre-
quencies (5% and 10%), larger combinations of screening
assays (similar to the previous ones but with additional as-
says) are needed and the expected saving on analysis cost
rapidly decreases. However, the GMO coverage is main-
tained at the same level.
The GMOseek algorithm is able to handle relatively
high percentage of GMO frequencies. The effect of fre-
quency change on GMO coverage is moderate but the
higher is the frequency, the lower is the cost saving pro-
vided by the screening combinations. However, it must
be observed that even when EU authorized and in pipe-
line GM events are very frequent (10%), very good
coverage (98%) and significant savings (close to 30% of
the initial costs) can be obtained using GMOseek. Note
that in some cases (current GMO frequencies, 5%, 10%),
the best combination proposed by GMOseek provides
only little advantage in terms of cost savings compared
to the previously proposed assay combination(s) for
similar GMO coverage.Near Future 1
In this scenario, at the first frequency level (1%), the
coverage and expected cost saving of the best com-
binations are comparable with those observed with
combination obtained using the “template data set”.
Logically, the expected cost saving decreases rapidly with
increasing GMO frequency while coverage and proposed
combinations remains mostly unchanged. However, it
must be observed that even when EU authorized and in-
pipeline GMOs are very frequent (10%), very good
coverage and significant savings can be obtained using
GMOseek. Further details on the results for these simu-
lations can be found in Additional file 27.
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In this scenario, at the first frequency level (1%), the
coverage and expected cost saving of the best combina-
tions are better than those observed for the combination
obtained with the “template data set” and for the near
future 1 scenario. Also for the other level of GMO fre-
quency, for similar coverage and combinations, better cost
savings are expected than for the near future 1 scenario.
Logically, the expected cost saving decreases rapidly with
increasing GMO frequency while coverage and proposed
combinations remains mostly unchanged. However, it
must be observed that even when EU authorized and
in-pipeline GMOs are very frequent (10%), very good
coverage and significant savings can be obtained using
GMOseek. Further details on the results for these simula-
tions can be found in Additional file 28.
Near Future 3
Results for this scenario in terms of proposed combi-
nation, cost saving and GMO coverage are quite com-
parable to those of the scenario near future 2. Further
details on the results for these simulations can be found
in Additional file 29.
As a conclusion of the simulations done based in these
scenarios, using GMOseek for choosing the best combi-
nations of screening assays (and therefore developing new
assays for future GMO status) always shows good results
in terms of GMO coverage and cost saving. These simula-
tions demonstrate the robustness of the algorithm as well
as the validity of using carefully chosen combinations of
screening assays for accurate and cost-efficient GMO de-
tection. Moreover, even with a very high frequency of GM
events (80%) as it is sometimes observed in feed samples,
GMOseek is still able to propose combinations enabling
significant cost savings. These results demonstrate that
the GMOseek algorithm could be a long lasting tool for
helping the analyst involved in GMO diagnostics.
Relevance of the results: test on real samples
Some real routine samples analyzed by the TestLab were
selected to evaluate the relevance of the matrix approach
proposed by GMOseek. To do so, the cost (directly linked
to the number of tests needed) and coverage of the con-
ventional testing strategy (screening the P35S and T-nos
and optionally GT73 genetic components, followed by
event-specific analysis) previously used by the TestLab
were compared with those of the strategy proposed by
GMOseek. Comparison was also made with the previously
described fixed five-components screening strategy (5plex)
[12] making use of the 5plex data subsets. Methods and
results of these simulations are available in Additional
file 30.
The optimal combination proposed by GMOseek always
offers better coverage (with one exception) and bettercost-efficiency than the 5plex combination approach. In
all cases, both GMOseek and 5plex combinations provide
better coverage and cost-efficiency than the P35S x t-NOS
(and sometimes GT73) screening phase previously used
by the TestLab (Figure 4). Therefore, the use of GMOseek
is relevant when tested on real samples and would, in
every case, allow better cost efficiency for an equal or bet-
ter GMO coverage would it be used for routine GMO
testing thanks to its superior screening strategy and the
DSS leading to an easy interpretation of the testing results.
Moreover, the algorithm would be able to warn about the
discrepancies between the screening phase and identifica-
tion results, observed in two samples.
In routine analysis, screening a set of samples is most
commonly practiced. In practice, test labs usually receive
a batch of samples of the same type, or alternatively, if
different test samples are submitted, they often have the
same ingredients. In these cases, a single strategy should
be on all samples. If, in contrary, samples to be tested
are diverse, GMOseek proposes several combinations of
assays with near-optimal cost and coverage for each
sample. It is very straight forward to look for common
combination of assays satisfying the coverage and cost
targets set by the test laboratory. Moreover, one can
even adapt the combination proposed by right-clicking
the assays in the inspection panel. In conclusion and
based on the authors experience with the tool, the soft-
ware is well tuned to routine analyses.
Performance of GMOseek compared to GMOtrack
In all cases, GMOseek provides results leading to cheaper
total analytical costs with at least equal coverage of the GM
events. The larger the dataset, the superior are the cost-
efficiency and the coverage of the screening combinations
offered by GMOseek in comparison with those proposed
by GMOtrack. This observation is not a surprise as the
search strategy of GMOtrack restricts the number of com-
binations to evaluate and therefore the number of assays to
be performed in the screening phase. For this reason, the
default maximum number of assays is set to five in GMO-
track. The constraint optimization-based search strategy
adopted for GMOseek allows to submit much larger data-
sets, scrutinizing larger combinations and to propose larger
sets of screening assays. Consequently, cheaper solution
using more informative, larger sets of assays covering more
GM events can be obtained in a practical timeframe (from
a few seconds to a few minutes). As such, in addition to the
availability of a user-friendly graphical interface and a deci-
sion support system, GMOseek proves to be the right tool
to suggest combinations of screening assays.
Conclusions
The GMOseek software is a multifunction tool, proven
to facilitate routine analysis of GMOs in food, feed or
Figure 4 Comparison of the GMOseek, 5plex and conventional screening strategies performance. A: Total number of tests needed to
identify the GM events in the samples. Vertical axis: number of tests used during the screening and identification phases. B: Coverage of the
tested screening strategies. Vertical axis: % of the GM events of the dataset that are covered by the screening phase.
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interface with a decision support system which guides
the user through all three steps of the cost-efficient
matrix GMO testing approach: from the selection of
screening assays, deciding on the event-specific assays to
be performed and the final interpretation of results. Due
to its ability to simulate testing costs in future scenarios,
it can be used not only for routine laboratory testing,
but also for research. It is adapted to the current situ-
ation of GMOs commercialized worldwide and the algo-
rithm is robust to face the future changes in the status
of GMOs. It is easily tuned to new situations on the
market by changing the input data matrix. Thanks to its
flexibility and user-friendly interface, it should easily
find its way in GMO testing and methods developing
laboratories.
Possible improvements of the GMOseek system would
be a direct connection with the EUginius molecular regis-
try (http://euginius.eu/) currently in development, which
should keep updated the knowledge of the GM eventscommercialized or in pipeline, worldwide, as well as their
genetic components. With such link to the molecular
registry, automatic skimming of the genetic components
originating from the host species could be set-up to
optimize the combinations of screening assays. Finally, a
new functionality taking into account the increasing need
to perform multiplex tests (targeting several DNA se-
quences simultaneously) should be incorporated in the
software to refine the cost-efficiency calculation.
Availability and requirements
The GMOseek software is packed and deployed as one file
which is named GMOseek.jar. It can be placed at any lo-
cation suitable for a user. The program can be executed
by a double click on the file from a file manager or by java
-jar GMOseek.jar from the command line. The software
runs on any operating system which has java 1.5 or later
installed. The software is freely available at http://www.
gmoseek.com/gmoseek. The documentation files to facili-
tate GMOseek use are available at the same URL.
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Operating system(s): Platform independent which has




Any restrictions to use: GMOseek is open source
software issued under the GNU General Public License.Additional files
Additional file 1: GMO_EU_2005.tab. Tabulated file with frequencies
and genetic components of the different EU authorized GM events in
2005.
Additional file 2: GMO_EU_2008.tab. Tabulated file with frequencies
and genetic components of the different EU authorized GM events in
2008.
Additional file 3: GMO_EU_2010.tab. Tabulated file with frequencies
and genetic components of the different EU authorized GM events in
2010.
Additional file 4: GMO_EU_2012.tab. Tabulated file with frequencies
and genetic components of the different EU authorized GM events in
2012.
Additional file 5: GMO_all_2012.tab. Tabulated file with frequencies
and genetic components of all known GM events in 2012.
Additional file 6: Actual frequency EU.tab. Tabulated file with TestLab
observed frequencies used for robustness test.
Additional file 7: EUv0_1.tab. Tabulated file with all GMO frequencies
from the actual frequency EU.tab file set to 0.1%. Used for robustness
test.
Additional file 8: EUv1.tab. Tabulated file with all GMO frequencies
from the actual frequency EU.tab file set to 1%. Used for robustness test.
Additional file 9: EUv2.tab. Tabulated file with all GMO frequencies
from the actual frequency EU.tab file set to 2%. Used for robustness test.
Additional file 10: EUv5.tab. Tabulated file with all GMO frequencies
from the actual frequency EU.tab file set to 5%. Used for robustness test.
Additional file 11: EUv10.tab. Tabulated file with all GMO frequencies
from the actual frequency EU.tab file set to 10%. Used for robustness test.
Additional file 12: EUnearfuture1v1.tab. Tabulated file simulating
near future scenario 1 with EU GMO frequencies set to 1%. Used for
robustness test.
Additional file 13: EUnearfuture1v2.tab. Tabulated file simulating near
future scenario 1 with EU GMO frequencies set to 2%. Used for
robustness test.
Additional file 14: EUnearfuture1v5.tab. Tabulated file simulating
near future scenario 1 with EU GMO frequencies set to 5%. Used for
robustness test.
Additional file 15: EUnearfuture1v10.tab. Tabulated file simulating
near future scenario 1 with EU GMO frequencies set to 10%. Used for
robustness test.
Additional file 16: EUnearfuture2v1.tab. Tabulated file simulating
near future scenario 2 with EU GMO frequencies set to 1%. Used for
robustness test.
Additional file 17: EUnearfuture2v2.tab. Tabulated file simulating
near future scenario 2 with EU GMO frequencies set to 2%. Used for
robustness test.
Additional file 18: EUnearfuture2v5.tab. Tabulated file simulating
near future scenario 2 with EU GMO frequencies set to 5%. Used for
robustness test.Additional file 19: EUnearfuture2v10.tab. Tabulated file simulating
near future scenario 2 with EU GMO frequencies set to 10%. Used for
robustness test.
Additional file 20: EUnearfuture3v1.tab. Tabulated file simulating
near future scenario 3 with EU GMO frequencies set to 1%. Used for
robustness test.
Additional file 21: EUnearfuture3v2.tab. Tabulated file simulating near
future scenario3 with EU GMO frequencies set to 2%. Used for robustness
test.
Additional file 22: EUnearfuture3v5.tab. Tabulated file simulating
near future scenario 3 with EU GMO frequencies set to 5%. Used for
robustness test.
Additional file 23: EUnearfuture3v10.tab. Tabulated file simulating
near future scenario 3 with EU GMO frequencies set to 10%. Used for
robustness test. .bis: EUnearfuture3v80_1.tab. Tabulated file simulating
near future scenario 3 with EU GMO frequencies set to 10% and one GM
event at 80%. Used for robustness test. ter: EUnearfuture3v80_4.tab.
Tabulated file simulating near future scenario 3 with EU GMO frequencies
set to 10% and four GM events at 80%. Used for robustness test.
Additional file 24: Template_5plex_test.tab. Tabulated file used as
template to create the 5plex subset. Used for comparing the GMOseek,
5plex and old screening strategies.
Additional file 25: Dataset_5_components.tab. Tabulated file used to
perform the 5plex strategy evaluation. Used for comparing the GMOseek,
5plex and old screening strategies.
Additional file 26: Raw results of the GMOseek robustness tests
performed with equal frequencies.
Additional file 27: Raw results of the GMOseek robustness tests
performed with the scenario “near future 1”.
Additional file 28: Raw results of the GMOseek robustness tests
performed with the scenario “near future 2”.
Additional file 29: Raw results of the GMOseek robustness tests
performed with the scenario “near future 3”.
Additional file 30: Methods and results of the comparison between
different screening strategies: previous P35S + t-NOS (GT73), 5plex
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